Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis

Atopic keratoconjunctivitis (AKC) is a chronic eye disease with periods of exacerbations. Many patients experience no obvious seasonal variation, although a majority of patients are allergic to common airborne allergens.

[1]  K. Tsubota,et al.  Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease , 2010, Molecular vision.

[2]  S. Whitcup,et al.  Cytokine and chemokine levels in tears from healthy subjects , 2010, Acta ophthalmologica.

[3]  J. Grunewald,et al.  Allergen provocation increases TH2‐cytokines and FOXP3 expression in the asthmatic lung , 2010, Allergy.

[4]  W. Fokkens,et al.  Nasal endothelial interleukin‐10 expression is negatively correlated with nasal symptoms after allergen provocation , 2009, Allergy.

[5]  J. Shoji,et al.  Concentration of Soluble Interleukin-6 Receptors in Tears of Allergic Conjunctival Disease Patients , 2007, Japanese Journal of Ophthalmology.

[6]  E. Chryssanthou,et al.  Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis , 2007, Eye.

[7]  M. Plebani,et al.  Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. , 2006, Acta ophthalmologica Scandinavica.

[8]  H. Zhan,et al.  Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  S. Sonoda,et al.  Alteration of tear cytokine balance by eye closure: analysis by multicytokine assay , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[10]  M. Plebani,et al.  Th1- and Th2-type cytokines in chronic ocular allergy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  E. Chryssanthou,et al.  No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  L. Borish,et al.  Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  K. Iwatsuki,et al.  Biphasic cytokine expression by T cell clones from patients with atopic dermatitis with different incubation periods and strengths of stimuli. , 2001, Fukushima journal of medical science.

[14]  S. Holgate,et al.  Tear and conjunctival changes during the allergen-induced early- and late-phase responses. , 2000, The Journal of allergy and clinical immunology.

[15]  A. Musani,et al.  Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects. , 2000, The Journal of allergy and clinical immunology.

[16]  E. Uchio,et al.  Tear levels of interferon‐γ, interleukin (IL) ‐2, IL‐4 and IL‐5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  Calder,et al.  Cytokine production and mRNA expression by conjunctival T‐cell lines in chronic allergic eye disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  M. Hingorani,et al.  The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. , 1999, Investigative ophthalmology & visual science.

[19]  M. Abelson,et al.  The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[20]  M. Hingorani,et al.  T-cell cytokines in chronic allergic eye disease. , 1997, The Journal of allergy and clinical immunology.

[21]  O. Zetterström,et al.  Sustained eosinophil cationic protein release into tears after a single high‐dose conjunctival allergen challenge , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  S. Wenzel,et al.  Interleukin-10 regulation in normal subjects and patients with asthma. , 1996, Journal of Allergy and Clinical Immunology.

[23]  C. Bruijnzeel-Koomen,et al.  Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. , 1996, The Journal of allergy and clinical immunology.

[24]  L. Lichtenstein,et al.  IL-13 expression at the sites of allergen challenge in patients with asthma. , 1995, Journal of immunology.

[25]  S. Tuft,et al.  Clinical features of atopic keratoconjunctivitis. , 1991, Ophthalmology.

[26]  S. Bonini,et al.  Allergen dose response and late symptoms in a human model of ocular allergy. , 1990, The Journal of allergy and clinical immunology.

[27]  B. Björkstén,et al.  The Precision of the Conjunctival Provocation Test , 1984, Allergy.

[28]  T. Iwasaki,et al.  [Ocular complications of atopic dermatitis]. , 1997, Nippon Ganka Gakkai zasshi.

[29]  S. Bonini,et al.  Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis. , 1992, The Journal of allergy and clinical immunology.

[30]  W. Chambers,et al.  Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. , 1990, Archives of ophthalmology.